home / stock / bfri / bfri news

BFRI News and Press, Biofrontera Inc. From 12/07/21

Stock Information
Company Name: Biofrontera Inc.
Stock Symbol: BFRI
Market: NASDAQ
Website: biofrontera-us.com
Menu
BFRI BFRI Quote BFRI Short BFRI News BFRI Articles BFRI Message Board
Get BFRI Alerts

News, Short Squeeze, Breakout and More Instantly...
BFRI - 3 Low Float Penny Stocks To Watch After ENSC Stock Soared

When you’re looking for penny stocks to buy, there is plenty to consider. The risk and reward factor is one of these things, of course. But you’ve also got to account for each company’s fundamental and technical aspects. Remember that we’re also mainly talking ab...
BFRI - Biofrontera Inc. Enrolls First Subject in Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz®

WOBURN, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the first subject has been enrolled in a Phase 1 study to evaluate the safety and ...

BFRI - Celyad Oncology, Longeveron leads healthcare gainers; Esperion Therapeutics, Biofrontera among major losers

Gainers: Celyad Oncology CYAD +41%, Longeveron LGVN +28%, Petros Pharmaceuticals (NASDAQ:PTPI) +26%, AirSculpt Technologies AIRS +12%, Werewolf Therapeutics (NASDAQ:HOWL) +12%. Losers: Esperion Therapeutics ESPR -40%, Biofrontera (NASDAQ:...

BFRI - EXPR Stock: 7 Reasons Why Express Investors Are Feeling Giddy Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors in Express (NYSE: EXPR ) stock are celebrating on Thursday thanks to the release of the company’s Q3 2021 earnings report. Source: Helen89 / Shutterstock.com Let’s break down that earni...
BFRI - NLSP, DAWN and MDJH among Mid-day movers

Gainers: Biofrontera (NASDAQ:BFRI) +36%. CF Acquisition (NASDAQ:CFVIU) +19%. Day One (NASDAQ:DAWN) +16%. Terns Pharmaceuticals (NASDAQ:TERN) +15%. Duluth Holdings (NASDAQ:DLTH) +15%. Snowflake (NYSE:SNOW) +14%. Aurinia Pharmaceuticals (NASDAQ:AUPH) +14%. Express (NYSE:EXPR) +13%. Vor Biopharm...

BFRI - BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biofrontera (NASDAQ: BFRI ) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office (USPTO). Source: Bukhta Yurii / Shutterstock.com According to a news rele...

BFRI - Biofrontera gains on patent win for photodynamic therapy

Biofrontera (BFRI +28.3%) is surging in the pre-market after announcing that the U.S. regulators issued a Notice of Allowance for a patent covering the photodynamic therapy (PDT), a focus area for the biopharma company. The U.S. patent application number 17/234,490 titled “Illumination...
BFRI - Biofrontera, Terns Pharmaceuticals leads healthcare gainers; Context Therapeutics, 180 Life Sciences among major losers

Gainers: Biofrontera (NASDAQ:BFRI) +29%, Terns Pharmaceuticals (NASDAQ:TERN) +20%, Aurinia Pharmaceuticals (NASDAQ:AUPH) +17%, Atreca (NASDAQ:BCEL) +12%, 4D pharma (NASDAQ:LBPS) +9%. Losers: Context Therapeutics (NASDAQ:CNTX) -29%, 180 Life Sc...

BFRI - Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on Innovative Illumination Protocol

WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) , a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allo...

BFRI - Biofrontera Inc. Announces Closing of $15 Million Private Placement

WOBURN, MA., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc . (Nasdaq: BFRI; BFRIW) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced the closing of a private placement with a single instit...
Previous 10 Next 10